Related references
Note: Only part of the references are listed.ACOG Practice Bulletin No. 103: Hereditary Breast and Ovarian Cancer Syndrome
OBSTETRICS AND GYNECOLOGY (2014)
Unraveling the Next Chapter Sexual Development, Body Image, and Sexual Functioning in Female BRCA Carriers
Ellen T. Matloff et al.
CANCER JOURNAL (2009)
Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers
Angela R. Bradbury et al.
GENETICS IN MEDICINE (2008)
The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy
Joanna B. Madalinska et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation
Amy Finch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers:: a prospective cohort study
SM Domchek et al.
LANCET ONCOLOGY (2006)
Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer
JB Madalinska et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Screening for familial ovarian cancer: Failure of current protocols to detect ovarian cancer at an early stage according to the International Federation of Gynecology and Obstetrics System
D Stirling et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
ND Kauff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
TR Rebbeck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Deciding about prophylactic oophorectomy: What is important to women at increased risk of ovarian cancer?
A Fry et al.
PREVENTIVE MEDICINE (2001)
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation
EJ Meijers-Heijboer et al.
LANCET (2000)
Share Paper
